What’s next for GLP-1s? — Harvard Gazette
Now that GLP-1 drugs have revolutionized how millions of Americans treat obesity and Type 2 diabetes, scientists are exploring the benefits of using the drugs for a host of other…
Now that GLP-1 drugs have revolutionized how millions of Americans treat obesity and Type 2 diabetes, scientists are exploring the benefits of using the drugs for a host of other…
There is no denying that diabetes is one of the deadliest chronic diseases of all time. Once you fall prey to this disease, it’s a lifelong battle to manage it…
A research project supported by FAPESP and carried out at Harvard University in the United States has identified a set of metabolites that move from the intestine to the liver…
We’ve been doing low carb diets wrong for 100 years. Viva Longevity’s mission is to find scientists who can cut through the fog of …
Students from the Harvard School of Engineering and Applied Sciences developed a storage container capable of maintaining, monitoring, and displaying its interior temperature to ensure drugs like insulin are kept…
Doug Melton's life irreparably changed the day his child was diagnosed with a life-threatening illness. But unlike most other parents in that situation, he was a molecular biologist who set…